ONC Disclosures

ECLIPSE v3 Spectrum – 2015 Cures Edition

ECLIPSE v3 Spectrum is a set of Health IT modules certified as 2015 Cures Edition compliant by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Vendor: MPN Software Systems, Inc.
Product Version: ECLIPSE v3 Spectrum
Date Certified: December 27, 2022
CHPL Date Listed: December 27, 2022
CHPL Last Modified Date: December 28, 2022
Certified Edition: 2015 Cures Update Edition
Certification ID Number(s): 15.04.04.1853.ECLI.03.01.1.221227

Modules Tested and Certified:
170.315(a)(1,2,3,5,9,12,14,15), 170.315(b)(1,2,10), 170.315(c)(1,2,3), 170.315(d)(1,2,3,4,5,6,7,8,9,12,13), 170.315(e)(1,2,3), 170.315(f)(1,2),170.315(g)(2,3,4,5,6,7,9,10),170.315(h)(1).

Tested and Certified Clinical Quality Measures:
CMS 50, CMS68, CMS 69, CMS 90, CMS 117, CMS 122, CMS 127, CMS 138, CMS 139, CMS 147, CMS 155, CMS 164, CMS 165, CMS 166

Additional Software Required: DrFirst, Medline Plus, RxNav

Price Transparency Statement: An annual subscription fee and yearly charges for 3rd-party solutions (DrFirst) are associated with the ONC Certified ECLIPSE.

Limitations: Aside from what has been disclosed above, there are no contractual limitations related to the certified product that would limit the user’s ability to use any of the capabilities that the technology is certified to.

  • Click here to review the 2024 ECLIPSE Spectrum Real World Testing Plan.
  • Click here to review the 2023 ECLIPSE Spectrum Real World Testing Plan & click here for the results.
  • Click here to review the 2022 ECLIPSE Spectrum Real World Testing Plan & click here for the results.